PT  - JOURNAL ARTICLE
AU  - Lana Ferguson
AU  - Stacey Hooper
TI  - Dexmedetomidine withdrawal syndrome and opioid sensitivity
AID  - 10.1136/bmjspcare-2020-002705
DP  - 2020 Dec 22
TA  - BMJ Supportive &amp;amp; Palliative Care
PG  - bmjspcare-2020-002705
4099  - http://spcare.bmj.com/content/early/2021/09/26/bmjspcare-2020-002705.short
4100  - http://spcare.bmj.com/content/early/2021/09/26/bmjspcare-2020-002705.full
AB  - This case report describes the use of dexmedetomidine for refractory cancer pain management in a patient with significant pelvic disease due to metastatic urothelial cancer. Specifically, the management of increased opioid sensitivity secondary to dexmedetomidine is discussed. Further, the phenomenon of dexmedetomidine withdrawal syndrome and our management of this is addressed.